$ARX

RADKE JEFFREY L sold $1.1M of ARX (indirect holdings)

RADKE JEFFREY L (Co-Founder, CEO) sold 80,000 indirectly-held shares of Accelerant Holdings (ARX) at $13.18 ($1.05M total) on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RADKE JEFFREY L
Published Jul 14, 2026, 10:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 10:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ARX
Neutral
high confidence
Mentioned
$ARX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The newest fact is the specific sale size, price, and that it occurred under a pre-arranged Rule 10b5-1 plan; there is no mention of earnings, guidance, contracts, or regulatory actions.

02

Market read

Traders may note the insider sale for sentiment/positioning, but the 10b5-1 framing reduces fundamental interpretation.

03

What to watch

The sale is indirect and pre-arranged; without context on total planned volume, timing, and remaining holdings, the signal strength is limited.

Relevance 5/10Novelty 5/10Timing: Filed on 2026-07-14 after-hours, reflecting a 2026-07-13 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX), reported by co-founder/CEO Jeffrey L. Radke.

Company-level read

Ticker impact

$ARXNeutralHigh confidence
Context

Form 4 shows co-founder/CEO Jeffrey L. Radke sold 80,000 shares of Accelerant Holdings at $13.1762 on 2026-07-13 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect is more about optics than new company information.

Evidence & confidence

The filing is a primary-source Form 4, but it specifies a pre-arranged 10b5-1 plan and provides no accompanying operational or guidance change.

Market effects

No sector read-through; the disclosure is company-specific and does not cite industry/regulatory developments.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with periods of valuation or liquidity needs, which some traders may treat as a mild negative signal.

Key entities

  • Accelerant Holdings

    Company whose shares were sold in the reported insider transaction.

  • RADKE JEFFREY L

    Co-Founder, CEO, and 10% owner who reported the sale on Form 4.

Related articles

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

$ARXMed

Accelerant Holdings Stock Rises 10%

Accelerant Holdings (ARX) shares rose 9.73% to $12.86 on Wednesday after the company said it expanded a partnership with Incline P&C Group. Effective July 1, 2026, Incline will act as a fronting carrier for over $500 million in annual gross written premiums across Accelerant’s U.S. commercial specialty insurance portfolio.

$ARXMedAI 8/10

Oil Volatility Is Back: 3 Canadian Stocks to Buy Now

The article says oil and gas prices remain volatile and highlights three Canadian energy stocks. Tourmaline Oil (TOU) reported record Q1 production and expects higher free cash flow in 2026-27, planning a $0.50 quarterly base dividend (yield ~3.1%). Birchcliff (BIR) reported strong Q1 2026 results and a $0.03 quarterly dividend. ARC Resources (ARX) reported Q1 2026 net income of $584m ($1.03/share) and agreed to be acquired by Shell in a ~$16.4bn deal including debt.